These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 29283221)

  • 1. Tumor Microenvironment-Enabled Nanotherapy.
    Wang L; Huo M; Chen Y; Shi J
    Adv Healthc Mater; 2018 Apr; 7(8):e1701156. PubMed ID: 29283221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotherapy Targeting the Tumor Microenvironment.
    Gong BS; Wang R; Xu HX; Miao MY; Yao ZZ
    Curr Cancer Drug Targets; 2019; 19(7):525-533. PubMed ID: 30569855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Tumor Microenvironment as a Barrier to Cancer Nanotherapy.
    Curtis LT; Frieboes HB
    Adv Exp Med Biol; 2016; 936():165-190. PubMed ID: 27739048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.
    Sa P; Sahoo SK; Dilnawaz F
    Curr Med Chem; 2023; 30(29):3335-3355. PubMed ID: 36154585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics.
    Chen Q; Liu G; Liu S; Su H; Wang Y; Li J; Luo C
    Trends Pharmacol Sci; 2018 Jan; 39(1):59-74. PubMed ID: 29153879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor microenvironment-responsive nanoparticles for cancer theragnostic applications.
    Uthaman S; Huh KM; Park IK
    Biomater Res; 2018; 22():22. PubMed ID: 30155269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
    Danhier F
    J Control Release; 2016 Dec; 244(Pt A):108-121. PubMed ID: 27871992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
    Muntimadugu E; Kommineni N; Khan W
    Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional MnO
    Yang G; Ji J; Liu Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1720. PubMed ID: 33908171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy.
    Truffi M; Mazzucchelli S; Bonizzi A; Sorrentino L; Allevi R; Vanna R; Morasso C; Corsi F
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagenase-Encapsulated pH-Responsive Nanoscale Coordination Polymers for Tumor Microenvironment Modulation and Enhanced Photodynamic Nanomedicine.
    Liu J; Tian L; Zhang R; Dong Z; Wang H; Liu Z
    ACS Appl Mater Interfaces; 2018 Dec; 10(50):43493-43502. PubMed ID: 30468076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering metal-phenolic networks for enhancing cancer therapy by tumor microenvironment modulation.
    Xie L; Li J; Wang L; Dai Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(3):e1864. PubMed ID: 36333962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-selective catalytic nanomedicine by nanocatalyst delivery.
    Huo M; Wang L; Chen Y; Shi J
    Nat Commun; 2017 Aug; 8(1):357. PubMed ID: 28842577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles Targeting and Remodeling Tumor Microenvironment for Cancer Theranostics.
    Lin G; Chen S; Mi P
    J Biomed Nanotechnol; 2018 Jul; 14(7):1189-1207. PubMed ID: 29944095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance.
    Fakhri S; Moradi SZ; Faraji F; Farhadi T; Hesami O; Iranpanah A; Webber K; Bishayee A
    Cancer Metastasis Rev; 2023 Sep; 42(3):959-1020. PubMed ID: 37505336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the role of components of the tumor microenvironment in oral carcinoma call for new therapeutic approaches.
    Salo T; Vered M; Bello IO; Nyberg P; Bitu CC; Zlotogorski Hurvitz A; Dayan D
    Exp Cell Res; 2014 Jul; 325(2):58-64. PubMed ID: 24462456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor self-responsive upconversion nanomedicines for theranostic applications.
    Xu J; Gulzar A; Yang D; Gai S; He F; Yang P
    Nanoscale; 2019 Oct; 11(38):17535-17556. PubMed ID: 31553008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles.
    Niu Y; Zhu J; Li Y; Shi H; Gong Y; Li R; Huo Q; Ma T; Liu Y
    J Control Release; 2018 May; 277():35-47. PubMed ID: 29545106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.